StockData
Pluri Inc. logo

Pluri Inc. (PLUR) income statement

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.94−0.03 (-3.07%)

Close on Nov 20, 2026Market cap $11.60MP/E –Yield –

See a number that looks wrong?